Pictet新兴市场崛起经济体主动型ETF RISE 深 沪
等待开盘 11-12 09:30:00 美东时间
17.8663
-0.038
-0.21%
华盛通- 最 高17.8663
- 今 开17.9046
- 成交量 35股
- 最 低 17.8663
- 昨 收 17.9046
- 总市值 2099.29万
- 52周最高 19.435
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 17.2664
- 委 比 0.00%
- 总股本 117.50万
- 历史最高 19.435
- 量 比 0.03
- 振 幅 0.00%
- 历史最低 17.2719
- 每 手 1
- 风险率 0.50%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BioVie Invited to Present Data on Bezisterim in Parkinson’s Disease at the AD/PD2027 International Conference on Alzheimer's & Parkinson’s Diseases
BioVie Inc. announced its invitation to present two oral sessions at the AD/PD2027 conference in Barcelona, highlighting findings from its Phase II SUNRISE-PD trial of bezisterim for Parkinson's disease. The presentations will focus on the drug's effects on disease progression markers and clinical outcomes, particularly in patients with higher baseline inflammation. Results showed significant improvements in motor and non-motor symptoms, with pat...
11-10 13:00
SAB BIO to Participate in Upcoming Investor Conferences
SAB Biotherapeutics announced that its management team will participate in several investor conferences in November and December 2026. CEO Samuel J. Reich will lead Fireside Chats at the Jefferies Global Healthcare Conference on November 16, the UBS Global Biopharma Conference on November 17, and the Evercore Healthcare Conference on December 1. Additionally, the company will hold one-on-one meetings during the Citi Global Healthcare Conference o...
11-09 13:30
SenesTech Expands E-Commerce Reach Through Walmart Fulfillment Services
SenesTech, Inc. announced that its Evolve® rodent control products are now available through Walmart Fulfillment Services (WFS), enhancing its e-commerce capabilities. This partnership improves delivery speed, convenience, and nationwide reach, while reducing fulfillment costs and supporting business growth. WFS integration has already boosted sales on Walmart.com, aligning with SenesTech's strategy to expand e-commerce and accessibility for sust...
11-03 20:00
BioVie Selected for Late-Breaking Oral Presentation of Bezisterim Long COVID Data at the 4th Long COVID International Conference 2026
BioVie Inc. has been invited to present late-breaking data on its drug Bezisterim at the 4th Long COVID International Conference. The presentation will highlight findings from the Phase 2 ADDRESS-LC trial, showing significant improvements in fatigue, post-exertional malaise, and cognition in high-symptom-burden patients with Long COVID. Bezisterim, which targets neuroinflammation, has demonstrated potential in reducing symptoms linked to persiste...
11-02 14:00
Sandstrom Partners Hired As Strategic Advisor on Marketing and Branding
SenesTech, a leader in rodent control, has enlisted Sandstrom Partners as a strategic advisor to boost e-commerce and B2B sales growth. Sandstrom, renowned for brand development, will provide services including market research, brand strategy, and digital design to enhance SenesTech's communication with customers. SenesTech's Evolve and ContraPest products, which use non-lethal methods to control rodent populations, have shown significant success...
10-28 12:00
